Buprenorphine hemiadipate

DB16117InvestigationalSmall molecule

Buprenorphine hemiadipate is under investigation in clinical trial NCT01582347 (Transfer of Subjects From Subutex/suboxone to RBP-6300).

Formula / weight: C₃₅H₄₉NO₇ · 595.777 g/mol (avg)
Also known as: Buprenorphine adipate ester

Resolves to

Compound

UNII968KUA5J54CAS951123-45-8

Structure

InChIKeyCVIJJOARNCQGON-XYQNZYJMSA-NSMILES[H][C@@]12OC3=C4C(C[C@H]5N(CC6CC6)CC[C@@]14[C@@]51CC[C@@]2(OC)[C@]([H])(C1)[C@](C)(O)C(C)(C)C)=CC=C3OC(=O)CCCCC(O)=O

What you can answer from here — as of April 02, 2025

1Clinical trialPhase, status and sponsor resolved per trial

Which companies are running trials of Buprenorphine hemiadipate, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account